Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. SHSSX: which is better?

Bottom line

PRHSX vs SHSSX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 72% by weight.

PRHSX is cheaper at 0.83% vs 0.86% — a difference of $3.00 a year per $10,000 invested.

Over five years, SHSSX returned +5.9% a year vs +4.2% for PRHSX.

Updated Nov 19, 2026

PRHSX vs SHSSX side by side

PRHSXSHSSX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceBlackRock
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.86%
Annual cost per $10k$83$86
10-yr cost on $10k (prospectus)$1,025$1,061
Max front load—0%
12b-1 fee—0%
1-yr return+17.7%+16.3%
5-yr return (annualized)+4.2%+5.9%
10-yr return (annualized)+9.1%+9.8%
Best quarter+23.5%—
Worst quarter−15.8%—
Net assets (fund)$11.9B$5.9B
Number of holdings279155
Portfolio turnover62%49%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

14 of PRHSX's top 25 holdings also appear in SHSSX's top 25.

Shared top holdings
HoldingPRHSXSHSSX
Eli Lilly & Co14.28%12.29%
Johnson & Johnson6.63%8.77%
Unitedhealth Group Inc5.99%6.10%
Abbvie Inc5.10%3.94%
Merck & Co. Inc.4.01%4.94%
Gilead Sciences Inc2.82%4.19%
Thermo Fisher Scientific Inc2.52%3.02%
Vertex Pharmaceuticals Inc2.28%2.74%
Abbott Laboratories1.89%1.97%
Intuitive Surgical Inc1.87%1.95%
Amgen Inc1.82%3.37%
Stryker Corp1.78%1.15%
Elevance Health Inc1.53%1.56%
Danaher Corp1.43%2.00%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

SHSSX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

FAQ

What is the difference between PRHSX and SHSSX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 72% by weight. PRHSX is cheaper at 0.83% vs 0.86% — a difference of $3.00 a year per $10,000 invested.
Which is cheaper, PRHSX or SHSSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and SHSSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.